Zacks Investment Research upgraded shares of Triple-S Management (NYSE:GTS) from a hold rating to a buy rating in a report published on Wednesday morning, Zacks.com reports. They currently have $28.00 target price on the stock.
According to Zacks, “Triple-S Management Corporation is an independent licensee of the Blue Cross Blue Shield Association. It is the largest managed care company in Puerto Rico, serving approximately one million members across all regions. Triple-S offers a broad portfolio of managed care and related products in the commercial, Medicare and Reform (similar to Medicaid) markets. In addition to its managed care business, Triple-S provides life and property and casualty insurance in Puerto Rico. “
Separately, ValuEngine lowered Zynerba Pharmaceuticals from a buy rating to a hold rating in a report on Tuesday, May 28th.
Shares of NYSE GTS opened at $24.74 on Wednesday. The firm has a market capitalization of $568.41 million, a price-to-earnings ratio of -16.06, a P/E/G ratio of 1.09 and a beta of 0.26. The firm’s 50-day moving average is $24.12. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.03. Triple-S Management has a 1-year low of $15.45 and a 1-year high of $39.07.
Triple-S Management (NYSE:GTS) last issued its earnings results on Thursday, May 9th. The company reported $0.77 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.51. Triple-S Management had a positive return on equity of 1.88% and a negative net margin of 1.06%. The company had revenue of $787.59 million during the quarter, compared to the consensus estimate of $769.21 million. During the same period last year, the business posted $0.60 EPS. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year. Sell-side analysts forecast that Triple-S Management will post 2.25 earnings per share for the current fiscal year.
Institutional investors and hedge funds have recently modified their holdings of the stock. Two Sigma Advisers LP increased its stake in Triple-S Management by 16.7% during the 4th quarter. Two Sigma Advisers LP now owns 166,735 shares of the company’s stock valued at $2,900,000 after purchasing an additional 23,799 shares in the last quarter. BlackRock Inc. increased its position in shares of Triple-S Management by 6.5% during the fourth quarter. BlackRock Inc. now owns 1,851,247 shares of the company’s stock worth $32,193,000 after acquiring an additional 112,411 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Triple-S Management during the first quarter worth about $266,000. Principal Financial Group Inc. acquired a new stake in shares of Triple-S Management in the 4th quarter worth about $187,000. Finally, Prudential Financial Inc. acquired a new stake in shares of Triple-S Management in the 4th quarter worth about $375,000. Institutional investors own 82.41% of the company’s stock.
Triple-S Management Company Profile
Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare Advantage, and Medicaid markets. It operates through three segments: Managed Care, Life Insurance, and Property and Casualty Insurance. The company offers various managed care products, including health maintenance organization plans; preferred provider organization plans; BlueCard program; Medicare Supplement products; Medicare Advantage products; Medicaid plans; and claims processing and other administrative services to employers, professional and trade associations, individuals, and government entities.
Recommended Story: Special Dividends
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Triple-S Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Triple-S Management and related companies with MarketBeat.com's FREE daily email newsletter.